Corpus Intelligence IC Memo — AURORA LAKELAND MEDICAL CENTER 2026-04-26 09:35 UTC
IC Memo — AURORA LAKELAND MEDICAL CENTER
Investment Committee Memorandum | WI | 62 beds | Grade C | EBITDA uplift $6.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AURORA LAKELAND MEDICAL CENTER

CCN 520102 | WALWORTH, WI | 62 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

AURORA LAKELAND MEDICAL CENTER is a 62-bed suburban community hospital in WALWORTH, WI with $83.6M in net patient revenue and a 12.1% operating margin. The hospital serves a payer mix of 34.4% Medicare, 3.3% Medicaid, and 62.3% commercial.

Thesis: Turnaround. Our ML models identify $6.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.1% to 19.5% (+736bps).

Net Revenue HCRIS$83.6M
Current EBITDA COMPUTED$10.1M
Operating Margin COMPUTED12.1%
Occupancy HCRIS51.3%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS28.1%
Distress Probability ML47.3%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
46
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 12.1% places it above the state median. Among 46 size-comparable peers (31-124 beds), the median margin is -5.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (31-124), prioritizing same-state peers. 46 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AURORA LAKELAND MEDICAL CENTER (Target)WI62$83.6M12.1%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
MCHS FRANCISCAN HEALTHCARE INWI103$413.8M-7.2%
ST. AGNES HOSPITALWI77$275.9M-3.0%
BELOIT MEMORIAL HOSPITAL INC.WI97$249.6M-3.0%
AURORA MEDICAL CENTER OF OSHKOWI79$222.3M17.9%
MARSHFIELD MEDICAL CENTER-EAU WI56$214.6M-21.8%
AURORA MEDICAL CTR SHEBOYGAN CWI116$211.8M7.7%
ASPIRUS STEVENS POINT HOSPITALWI82$201.4M28.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.8M+210bp18mo
Cost to Collect4.5%2.5%$1.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.0M+122bp9mo
Clean Claim Rate88.0%96.0%$54K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.8M
Cost to Collect
$1.7M
Denial Rate Reduction
$1.7M
A/R Days Reduction
$1.0M
Clean Claim Rate
$54K
Total EBITDA Uplift$6.2M
Current EBITDA$10.1M
+ RCM Uplift+$6.2M
Pro Forma EBITDA$16.3M
Current Margin12.1%
Pro Forma Margin19.5%
WC Released (1x)$3.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$15.6M$128.4M8.23x52.4%
Base (11x exit)10.0x11.0x$15.6M$146.3M9.38x56.5%
Bull Case9.0x11.0x$14.0M$171.7M12.23x65.0%
Bull (12x exit)9.0x12.0x$14.0M$191.4M13.64x68.6%
Bear Case11.0x10.0x$17.2M$92.6M5.40x40.1%
Bear (11x exit)11.0x11.0x$17.2M$107.4M6.26x44.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 46 hospitals with 31-124 beds
  • Same-state prioritization (n=47)
  • Comp margins: P25=-17.3% / P50=-5.2% / P75=13.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.